153 related articles for article (PubMed ID: 19037993)
1. Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.
Tamaki K; Moriya T; Sato Y; Ishida T; Maruo Y; Yoshinaga K; Ohuchi N; Sasano H
Cancer Sci; 2009 Jan; 100(1):88-94. PubMed ID: 19037993
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.
Tamaki K; Sasano H; Maruo Y; Takahashi Y; Miyashita M; Moriya T; Sato Y; Hirakawa H; Tamaki N; Watanabe M; Ishida T; Ohuchi N
Cancer Sci; 2010 Apr; 101(4):1051-8. PubMed ID: 20704578
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery.
Wang Q; Tian X; Zhang C; Wang Q
Med Oncol; 2012 Dec; 29(4):2727-36. PubMed ID: 22101788
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.
Yan Y; Shen Z; Ye Y; Jiang K; Zhang H; Shen C; Mustonen H; Puolakkainen P; Wang S
Med Oncol; 2014 Feb; 31(2):816. PubMed ID: 24366689
[TBL] [Abstract][Full Text] [Related]
6. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
[TBL] [Abstract][Full Text] [Related]
7. Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma--an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy.
Chan MS; Wang L; Chanplakorn N; Tamaki K; Ueno T; Toi M; Loo WT; Chow LW; Suzuki T; Sasano H
Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S69-78. PubMed ID: 22309693
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
[TBL] [Abstract][Full Text] [Related]
9. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
[TBL] [Abstract][Full Text] [Related]
11. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
Sato Y; Sonoda H
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
[TBL] [Abstract][Full Text] [Related]
12. Proliferation and maturation of intratumoral blood vessels in non-small cell lung cancer.
Yazdani S; Miki Y; Tamaki K; Ono K; Iwabuchi E; Abe K; Suzuki T; Sato Y; Kondo T; Sasano H
Hum Pathol; 2013 Aug; 44(8):1586-96. PubMed ID: 23522064
[TBL] [Abstract][Full Text] [Related]
13. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
14. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
Shen J; Yang X; Xiao WH; Hackett SF; Sato Y; Campochiaro PA
FASEB J; 2006 Apr; 20(6):723-5. PubMed ID: 16473886
[TBL] [Abstract][Full Text] [Related]
15. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast.
Teo NB; Shoker BS; Jarvis C; Martin L; Sloane JP; Holcombe C
Br J Cancer; 2002 Mar; 86(6):905-11. PubMed ID: 11953822
[TBL] [Abstract][Full Text] [Related]
16. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Yaegashi N; Sato Y
Cancer Sci; 2008 May; 99(5):914-9. PubMed ID: 18325046
[TBL] [Abstract][Full Text] [Related]
17. Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas.
Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Sasano H; Yaegashi N; Sato Y
Cancer Sci; 2011 Feb; 102(2):446-51. PubMed ID: 21175993
[TBL] [Abstract][Full Text] [Related]
18. Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis.
Hosaka T; Kimura H; Heishi T; Suzuki Y; Miyashita H; Ohta H; Sonoda H; Moriya T; Suzuki S; Kondo T; Sato Y
Am J Pathol; 2009 Jul; 175(1):430-9. PubMed ID: 19498005
[TBL] [Abstract][Full Text] [Related]
19. Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells.
Kozako T; Matsumoto N; Kuramoto Y; Sakata A; Motonagare R; Aikawa A; Imoto M; Toda A; Honda S; Shimeno H; Soeda S
FEBS Lett; 2012 Apr; 586(7):1067-72. PubMed ID: 22569265
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases.
Ozdemir BH; Akcali Z; Haberal M
Am J Clin Pathol; 2004 Nov; 122(5):696-703. PubMed ID: 15491965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
